FDA Announces New Standards to Help Women Detect Breast Cancer Earlier

The Food and Drug Administration (FDA) released new standards Thursday that could potentially help more women detect breast cancer earlier. Dense breast tissue, which refers to breasts composed of more fibroglandular tissue than fatty tissue, is a normal and common condition. The new rules will require mammogram providers nationwide to notify women if they have dense breast tissue and recommend that they consult with a doctor about whether they need additional screening.

Dr. Hilary Marston, the FDA’s chief medical officer, said in a statement that the changes “reflect advances in mammography technology and processes” and will strengthen the FDA’s oversight and enforcement while helping physicians better assess and categorize mammograms.

According to estimates from the American Cancer Society, more than 297,700 women will be diagnosed with invasive breast cancer this year, and about 43,700 will die from the disease. Early detection is key to increasing the chances of survival, and the new standards from the FDA could help more women detect breast cancer earlier.

The FDA is committed to supporting innovation to prevent, detect, and treat cancer. The new standards are an important step in helping to ensure that women are able to detect breast cancer as early as possible. It is important for women to be aware of their breast density and to consult with their doctor if they have any concerns.